US Stock MarketDetailed Quotes

ABCL AbCellera Biologics

Watchlist
  • 3.480
  • -0.040-1.14%
Close Jan 24 16:00 ET
  • 3.460
  • -0.020-0.57%
Post 20:01 ET
1.03BMarket Cap-5.70P/E (TTM)

AbCellera Biologics Key Stats

AbCellera Biologics Q4 2024 Estimates Date

Currency:USDFeb 27, 2025

Estimate YoY
Revenue
7.58M
-17.62%
EPS
-0.15
+8.57%
Strong Buy

Jan 8, 2025

AbCellera Biologics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 13.969M--
Feb 27, 20252024/Q4-- / 7.579M--
Nov 4, 20242024/Q36.507M / 8.015M--
Aug 6, 20242024/Q27.323M / 10.015M--
May 7, 20242024/Q19.954M / 11.005M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 13.969M--
Feb 27, 20252024/Q4-- / 7.579M--
Nov 4, 20242024/Q36.507M / 8.015M--
Aug 6, 20242024/Q27.323M / 10.015M--
May 7, 20242024/Q19.954M / 11.005M--

Unlock Free Earnings Estimates

AbCellera Biologics Earnings Reports

Read more

Trending Stocks

Discussing
U.S.-China talks spark interest, no more inflation?
🎙️Discussion: 1. How will Trump's China policies affect Chinese assets? 2. Which sectors might benefit as U.S. inflation risks decline? Show More